Conestoga Capital Advisors Lowers stake in Mesa Laboratories (MLAB)

Mesa Laboratories (MLAB) : Conestoga Capital Advisors reduced its stake in Mesa Laboratories by 20.55% during the most recent quarter end. The investment management company now holds a total of 350,454 shares of Mesa Laboratories which is valued at $43,123,365 after selling 90,652 shares in Mesa Laboratories , the firm said in a disclosure report filed with the SEC on Jul 22, 2016.Mesa Laboratories makes up approximately 3.14% of Conestoga Capital Advisors’s portfolio.

Other Hedge Funds, Including , Eqis Capital Management boosted its stake in MLAB in the latest quarter, The investment management firm added 154 additional shares and now holds a total of 3,091 shares of Mesa Laboratories which is valued at $379,791. Mesa Laboratories makes up approx 0.02% of Eqis Capital Management’s portfolio.

Mesa Laboratories closed down -3.92 points or -3.28% at $115.63 with 29,243 shares getting traded on Friday. Post opening the session at $119.11, the shares hit an intraday low of $115.63 and an intraday high of $120.05 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.

Investors should note that on Jul 6, 2016, Mesa Laboratories announced a cash dividend of $0.1600. The company’s management has announced Aug 29, 2016 as the ex-dividend date and fixed the record date on Aug 31, 2016. The payable date has been fixed on Sep 15, 2016.

Many Wall Street Analysts have commented on Mesa Laboratories. Mesa Laboratories was Downgraded by Sidoti to ” Neutral” on Jun 10, 2016.

Mesa Laboratories Inc. is primarily focused on quality control products. The Company has three segments: Instruments Biological Indicators and Continuous Monitoring. The Company’s Instruments segment designs manufactures and markets quality control instruments and disposable products utilized in connection with the healthcare pharmaceutical food and beverage medical device industrial hygiene environmental air sampling and semiconductor industries. Its Biological Indicators segment manufactures and markets biological indicators and distributes chemical indicators used to assess the effectiveness of sterilization processes in the hospital dental medical device and pharmaceutical industries. Its Continuous Monitoring segment designs develops and markets systems which are used to monitor various environmental parameters in hospitals pharmaceutical and medical device manufacturers blood banks pharmacies and a number of other laboratory and industrial environments.

Leave a Reply

Mesa Laboratories - Is it time to Sell?

Top Brokerage Firms are advising their investors on Mesa Laboratories. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.